In her role leading global partnerships for Bayer G4A, Zsuzsanna Varga has reviewed more than 5,000 applications from startups looking to make their way into one of the G4A digital health programs. The applications have come in from around the world – making Zsu of the most perfect people to ask about the global “state-of-play” of healthcare innovation.
Who’s good at innovating in medical devices? What countries excel at consumer engagement? How about complex IT solutions? What do digital health startups – regardless of where they are from – need to know to become successful in the healthcare market?
While at Health 2.0 EU / HIMSS Europe in May, Zsuzsanna and I got to chat about health innovation worldwide, and what startup founders can do to attract the attention of big healthcare companies like Bayer. While startups who apply to their programs don’t necessarily need to be able to scale across borders, it is helpful for consumer-focused applications so Zsu ticks through some of the challenges startups need to overcome. What do most startups underestimate when it comes to taking their solution into a new country? You’ll be surprised at the answer.